# Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer

> **NCT06893861** · — · RECRUITING · sponsor: **National Cancer Institute, Naples** · enrollment: 3100 (estimated)

## Conditions studied

- Endometrial Carcinoma (EC)

## Interventions

- **OTHER:** Metabolomic profiling

## Key facts

- **NCT ID:** NCT06893861
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-06
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 3100 (ESTIMATED)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06893861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06893861, "Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06893861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*